Gene therapy may activate stem cells in heart failure patients

February 22, 2013

Gene therapy may activate stem cells in heart failure patients
Delivery of an SDF-1 encoding plasmid acts a homing signal for stem cells and improves clinical status in patients with symptomatic heart failure due to ischemic cardiomyopathy, according to a study published online Feb. 21 in Circulation Research.
(HealthDay)—Delivery of an SDF-1 encoding plasmid (JVS-100) acts a homing signal for stem cells and improves clinical status in patients with symptomatic heart failure due to ischemic cardiomyopathy (IsCM), according to a study published online Feb. 21 in Circulation Research.

Marc Penn, M.D., from Summa Health System in Akron, Ohio, and colleagues conducted a phase I, open-label, dose-escalation study (5, 15, or 30 mg of JVS-100 via endomyocardial injection) with 12 months follow-up in subjects with IsCM. The 17 subjects had New York Heart Association (NYHA) Class III , with an ≤40 percent on stable medical therapy.

The researchers found that at one month and four months the primary safety end point of no major adverse cardiac events was met. All cohorts demonstrated improvements in six-minute walk distance (6MWd), quality of life (QOL), and NYHA class at four months. Improvements over baseline in 6MWd were seen in the 15-mg and 30-mg dose groups (15 mg: Median [Range]: 41 [3 to 61] m; 30 mg: 31 [22 to 74] m), as were improvements in QOL (15 mg: −16 [+1 to −32] points; 30 mg: −24 [+17 to −38] points). Improvements in symptoms were maintained at 12 months.

"These data highlight the importance of defining the of stem cell-based tissue repair and suggest that over-expression of SDF-1 via gene therapy is a strategy for improving heart failure symptoms in patients with IsCM," the authors write.

One author is named as an inventor on for the use of SDF-1 to treat cardiovascular disease that have been licensed by Juventas Therapeutics, which funded the study.

Explore further: Stem cell 'homing' signal may help treat heart failure patients

More information: Abstract
Full Text
Editorial

Related Stories

Stem cell 'homing' signal may help treat heart failure patients

February 21, 2013
In the first human study of its kind, researchers activated heart failure patients' stem cells with gene therapy to improve their symptoms, heart function and quality of life, according to a study in the American Heart Association ...

SCAI: Ixmyelocel-T studied for dilated cardiomyopathy

May 15, 2012
(HealthDay) -- For patients with dilated cardiomyopathy, treatment with an autologous bone marrow-derived, expanded multi-cell product, ixmyelocel-T, is well tolerated and associated with improved symptoms at one year, according ...

FDA: Zofran 32-mg dose pulled from market

December 6, 2012
(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...

FDA announces new limits on high-dose simvastatin (Zocor)

June 9, 2011
The United States Food and Drug Administration (FDA) today announced new limitations to the use of high-dose simvastatin, due to the increased risk of muscle pain and weakness (myopathy) and in rare cases, kidney damage and ...

Donepezil found helpful in dementia with lewy bodies

July 31, 2012
(HealthDay) -- For patients with dementia with Lewy bodies (DLB), treatment with 5 or 10 mg/day donepezil is associated with significant cognitive, behavioral, and global function improvements, according to research published ...

New therapy for heart failure may enhance body's stem cell response at cardiovascular injury site

February 21, 2013
Cardiovascular disease specialists at Florida Hospital Pepin Heart Institute and Dr. Kiran C. Patel Research Institute affiliated with the University of South Florida announced they have enrolled their first patients into ...

Recommended for you

Increasing statins dose and patient adherence could save more lives

December 7, 2018
Thousands of heart attacks and deaths from cardiovascular disease could be prevented by patients taking higher doses of statins and taking the drugs as advised by doctors.

Progress made in transplanting pig hearts into baboons

December 6, 2018
A large team of researchers from several institutions in Germany, Sweden, Switzerland and the U.S. has transplanted pig hearts into baboons and kept them alive for an extended period of time. In their paper published in the ...

Obesity ups survival in heart failure, but that's no reason to pile on pounds

December 6, 2018
(HealthDay)—Obese people with heart failure may live longer than those who are thinner—especially if they are "metabolically healthy," a new study suggests.

New genetic insight could help treat rare debilitating heart and lung condition

December 6, 2018
The largest study of genetic variation in patients with pulmonary arterial hypertension has associated two important genes with the disease.

New drug target discovered for potential blood pressure treatment

December 5, 2018
Scientists have identified a key player in blood pressure regulation and have shown that switching it off reduces blood pressure in mice, according to new research in eLife.

Neighborhoods with more green space may mean less heart disease

December 5, 2018
People who live in leafy, green neighborhoods may have a lower risk of developing heart disease and strokes, according to new research published in the Journal of the American Heart Association, the Open Access Journal of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.